Does Rheumatic Disease Increase Risk of MGUS Progression to Hematologic Malignancies?
Patients with monoclonal gammopathy of undetermined significance (MGUS) and concomitant non-antibody (Ab)–mediated inflammatory rheumatic diseases are at increased risk of progression to overt multiple...
More COVID-19 Complications Seen in Black Patients With Sickle Cell Disease and Sickle Cell...
Patients with sickle cell disease (SCD) and sickle cell trait (SCT) have significantly higher rates of hospitalization, pneumonia, and pain related to COVID-19 compared...
Tandem High-Dose Influenza Vaccine Offers Durable Seroprotection for Patients With Plasma Cell Dyscrasias
Tandem high-dose influenza vaccination may result in more durable serologic immunity in patients with plasma cell dyscrasias (PCDs), compared with standard vaccination, according to...
Can Caloric Restriction Improve Chemotherapy Response in Overweight Patients With ALL?
Previous reports have found that patients who are overweight or obese during B-cell acute lymphocytic leukemia (B-ALL) induction therapy are at a higher risk...
Why Are Individuals with Blood Group A at Higher Risk of COVID-19?
New findings published in Blood Advances suggest that SARS-CoV-2, the virus responsible for COVID-19, is particularly drawn to a blood A group antigen on...
Characterizing Complications Among Infants and Toddlers With von Willebrand Disease
A new report published in Blood Advances describes the experiences of infants and toddlers living with von Willebrand disease (VWD), highlighting the role and...
HLA-Haploidentical Relative and Matched Unrelated Donor Transplant Lead to Similar Survival Outcomes in MDS
Transplantation with an HLA-haploidentical relative donor is associated with similar two-year survival rates compared with transplantation with a matched unrelated donor in patients with...
Transplant Improves Health-Related Quality of Life for Patients With SCD and Transfusion-Dependent Thalassemia
Hematopoietic cell transplantation (HCT) is associated with significant improvements in health-related quality of life (HRQoL) in patients with sickle cell disease (SCD) and transfusion-dependent...
Older Age, Pre-Existing Comorbidities Increase Poor Outcomes in Patients With SCD and COVID-19
Patients with sickle cell disease (SCD) have poor outcomes associated with COVID-19, particularly if they are older or present with end organ damage, acute...
Large Meta-Analysis Confirms Predictive Value of MRD Negativity in Myeloma
Achievement of measurable residual disease (MRD) negativity is associated with significant improvements in progression-free survival (PFS) and overall survival (OS) in patients with multiple...
Current Issue
June 2021 Volume 7 Issue 7
This issue reviews the management and prevention of peripheral neuropathy, early successes of SCD screening programs in sub-Saharan Africa, and more.